Dr Sandhya Jagannathan, MD | |
100 Highway 28 W, Belle, MO 65013-3405 | |
(573) 859-3775 | |
(573) 859-3997 |
Full Name | Dr Sandhya Jagannathan |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 100 Highway 28 W, Belle, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962440594 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 2004012240 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sandhya Jagannathan, MD 1416 Overland Dr, Rolla, MO 65401-6817 Ph: (573) 426-2572 | Dr Sandhya Jagannathan, MD 100 Highway 28 W, Belle, MO 65013-3405 Ph: (573) 859-3775 |
News Archive
CSL Behring announced today that it has initiated an international phase I/II study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor (C1-INH) concentrate in patients with hereditary angioedema.
The ‘Care ethic to care ethos' report launched today at BT's Agile Business: Connected Lives conference in London, argues that the UK's care ethos is in danger as people reserve care for close family and friends.
Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.
Living in a rural setting and being unmarried were each linked to higher rates of hopelessness among people with heart disease, according to new research published today in the Journal of the American Heart Association, an open-access journal of the American Heart Association.
› Verified 2 days ago